Health Promotion Board, Singapore
13
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood Obesity
Role: collaborator
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
Role: collaborator
A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19
Role: collaborator
hiSG Sleep Health Study
Role: collaborator
Health@NUS - Studying Health Behaviours and Well-being During the Student-to-Work Life Transition Using mHealth
Role: collaborator
GluCoach - Technology-enabled Lifestyle Intervention Study
Role: collaborator
Regenerative Endodontic Therapy (RET) for the Management of Immature Non-vital Permanent Teeth in Children
Role: collaborator
Whole-exome Sequencing in Childhood Obesity
Role: collaborator
The Glycaemic Response of Local Foods Using the Continuous Glucose Monitoring System
Role: collaborator
Food Modification to Alter Glycaemia and Insulinaemia
Role: collaborator
A Randomized Trial of Economic Incentives to Promote Walking Among Full Time Employees
Role: collaborator
Community-based Falls Prevention Program for the Elderly
Role: collaborator
Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia
Role: collaborator
All 13 trials loaded